Cytokinetics | CYTK - مصروفات التشغيل





مصروفات التشغيل تغيير تاريخ
Acadia Pharmaceuticals USD 266.6M 23.72M 2025-12
Amgen USD 4.78B 1.12B 2026-03
Arca Biopharma USD 34.43M 326K 2025-12
Bayer EUR 10.33B 126M 2025-12
Biogen USD 1.96B 69.6M 2026-03
Brainstorm Cell Therapeutics USD 2.24M 197K 2025-12
Bristol-Myers Squibb USD 20.07B 11.77B 2026-03
Capricor Therapeutics USD 29.16M 2.87M 2025-12
Cytokinetics USD 200.58M 4.46M 2026-03
Eisai JPY 199.9B 16.22B 2025-12
Eli Lilly USD 10.02B 285M 2026-03
Exelixis USD 359.47M 3.28M 2026-03
Geron USD 58.8M 2.31M 2025-12
Halozyme Therapeutics USD 211.07M 74.73M 2025-12
Ionis Pharmaceuticals USD 364M 54M 2026-03
Ligand Pharmaceuticals USD 8.29M 32.17M 2025-09
Merck USD 18.17B 8.01B 2026-03
Novartis USD 9.29B 507M 2026-03
Pfizer USD 90.1B 77.19B 2026-03
Regeneron Pharmaceuticals USD 31.42B 28.44B 2026-03
Roche Holding CHF 21.01B 10.84B 2025-12
Sanofi EUR 9.31B 1.2B 2026-03